Sponsor pipeline

Tang-Du Hospital clinical trial pipeline

Get alerts when Tang-Du Hospital's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-02 NCT07854964 A Prospective, Single-center, Phase II Study of Neoadjuvant Serplulimab Plus XELOX and… Not Yet Recruiting

Active trials by phase

Phase 1
2
Phase 1/2
5
Phase 2
25
Phase 3
2
Phase 4
2
Not charted: 28 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 17

Lung Cancer (15) · Non-Small Cell Lung Cancer (NSCLC) (9) · Esophageal Cancer (7) · Small Cell Lung Cancer (5) · Stroke (4) · Head & Neck Cancer (3) · Myasthenia Gravis (3) · Ulcerative Colitis (3) · Breast Cancer (2) · Colorectal Cancer (2)

Get alerts when Tang-Du Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free